2,558
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients

, , , , , , , , , & show all
Pages 618-623 | Received 27 Sep 2011, Accepted 16 Dec 2011, Published online: 23 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ruizhi Zhao, Yuchao Ma, Siran Yang, Qingfeng Liu, Yuan Tang, Kai Wang, Ye Zhang, Nan Bi, Hongmei Zhang, Junlin Yi, Yexiong Li, Jingwei Luo & Jianping Xiao. (2020) Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience. Cancer Management and Research 12, pages 11563-11571.
Read now
Umberto Ricardi, Andrea Riccardo Filippi & Pierfrancesco Franco. (2013) New concepts and insights into the role of radiation therapy in extracranial metastatic disease. Expert Review of Anticancer Therapy 13:10, pages 1145-1155.
Read now
Kevin Shiue, Andrew Song, Bin S Teh, Rodney J Ellis, Min Yao, Nina A Mayr, Zhibin Huang, Jason Sohn, Mitchell Machtay & Simon S Lo. (2012) Stereotactic body radiation therapy for metastasis to the adrenal glands. Expert Review of Anticancer Therapy 12:12, pages 1613-1620.
Read now
Morten Høyer & Ludvig P. Muren. (2012) Stereotactic body radiation therapy – A discipline with Nordic origin and profile. Acta Oncologica 51:5, pages 564-567.
Read now

Articles from other publishers (58)

Xuehong Liao, Kazushi Kishi, Kaixin Du, Ritsuko Komaki, Junetsu Mizoe, Gosuke Aikawa, Wei Zheng & Chao Pan. (2023) Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis. Frontiers in Oncology 13.
Crossref
Tiziana Malatesta, Alessandro Scaggion, Francesca Romana Giglioli, Gina Belmonte, Michelina Casale, Paolo Colleoni, Maria Daniela Falco, Alessia Giuliano, Stefania Linsalata, Carmelo Marino, Eugenia Moretti, Veronica Richetto, Anna Sardo, Serenella Russo & Pietro Mancosu. (2023) Patient specific quality assurance in SBRT: a systematic review of measurement-based methods. Physics in Medicine & Biology 68:21, pages 21TR01.
Crossref
Justine Herndon, Christopher Hallemeier, Krishan Jethwa, Afreen Shariff & Irina Bancos. (2023) Radiation of bilateral adrenal metastases is associated with a high risk of primary adrenal insufficiency. Clinical Endocrinology 99:1, pages 35-42.
Crossref
Ciro Franzese, Sara Stefanini & Marta Scorsetti. (2023) Radiation Therapy in the Management of Adrenal Metastases. Seminars in Radiation Oncology 33:2, pages 193-202.
Crossref
Esra Kekilli & Taciser Demirkasımoğlu. (2023) The efficacy and outcomes of stereotactic body radiotherapy in adrenal gland metastases. Journal of Cancer Research and Therapeutics 19:8, pages 47.
Crossref
Indrin J. Chetty, Anthony J. Doemer, Jennifer L. Dolan, Joshua P. Kim, Justine M. Cunningham, Jadranka Dragovic, Aharon Feldman, Eleanor M. Walker, Mohamed Elshaikh, Khaled Adil, Benjamin Movsas & Parag J. Parikh. (2022) MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges. International Journal of Radiation Oncology*Biology*Physics 114:5, pages 950-967.
Crossref
Daniel Buergy, Florian Würschmidt, Eleni Gkika, Juliane Hörner‐Rieber, Stefan Knippen, Sabine Gerum, Panagiotis Balermpas, Christoph Henkenberens, Theresa Voglhuber, Christine Kornhuber, Steffen Barczyk, Barbara Röper, Ali Rashid, Oliver Blanck, Andrea Wittig, Hans‐Ulrich Herold, Thomas Baptist Brunner, Reinhart A. Sweeney, Klaus Henning Kahl, Ilja Frank Ciernik, Annette Ottinger, Victor Izaguirre, Florian Putz, Laila König, Michael Hoffmann, Stephanie Elisabeth Combs, Matthias Guckenberger & Judit Boda‐Heggemann. (2022) Stereotactic body radiotherapy of adrenal metastases—A dose‐finding study. International Journal of Cancer 151:3, pages 412-421.
Crossref
Daniel Buergy, Florian Würschmidt, Eleni Gkika, Juliane Hörner‐Rieber, Stefan Knippen, Sabine Gerum, Panagiotis Balermpas, Christoph Henkenberens, Theresa Voglhuber, Christine Kornhuber, Steffen Barczyk, Barbara Röper, Ali Rashid, Oliver Blanck, Andrea Wittig, Hans‐Ulrich Herold, Thomas B. Brunner, Rainer J. Klement, Klaus Henning Kahl, Ilja F. Ciernik, Annette Ottinger, Victor Izaguirre, Florian Putz, Laila König, Michael Hoffmann, Stephanie E. Combs, Matthias Guckenberger & Judit Boda‐Heggemann. (2021) Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis. International Journal of Cancer 149:2, pages 358-370.
Crossref
Hussein D. Aoun, Peter J. Littrup, Bashar Nahab, Michael Rizk, Matthew Prus, Julie Samantray, Donald Weaver, Ulka Vaishampayan & Edson Pontes. (2021) Percutaneous cryoablation of adrenal metastases: technical feasibility and safety. Abdominal Radiology 46:6, pages 2805-2813.
Crossref
Priscilla K. Stumpf, Ellen D. Yorke, Issam El Naqa, Kyle C. Cuneo, Jimm Grimm & Karyn A. Goodman. (2021) Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors. International Journal of Radiation Oncology*Biology*Physics 110:1, pages 217-226.
Crossref
Florian Eichhorn & Hauke Winter. (2021) How to handle oligometastatic disease in nonsmall cell lung cancer. European Respiratory Review 30:159, pages 200234.
Crossref
Joachim Pfannschmidt & Samantha Taber. (2021) Perspektiven in Diagnostik und Therapie des oligometastasierten Lungenkarzinoms. Der Nuklearmediziner 44:01, pages 55-62.
Crossref
Giuseppe Facondo, Gianluca Vullo, Maurizio Valeriani, Anna Maria Ascolese, Vitaliana De Sanctis & Mattia Falchetto Osti. (2021) Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.. Cancer Treatment and Research Communications 29, pages 100481.
Crossref
Laila König, Matthias F. Häfner, Sonja Katayama, Stefan A. Koerber, Eric Tonndorf-Martini, Denise Bernhardt, Bastian von Nettelbladt, Fabian Weykamp, Philipp Hoegen, Sebastian Klüter, Matthew S. Susko, Jürgen Debus & Juliane Hörner-Rieber. (2020) Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiation Oncology 15:1.
Crossref
Julia Malone, Jason R. Pantarotto, David Tiberi & Shawn Malone. (2020) Adrenal oligometastasis cured with stereotactic ablative radiotherapy. Radiology Case Reports 15:11, pages 2266-2270.
Crossref
Pınar Akın Kabalak, Derya Kızılgöz, Ülkü Yılmaz, Tuba İnal Cengiz, Evrim Tunç, Şebnem Yaman & Erkmen Gülhan. (2020) Treatment outcomes in oligometastatic non‐small‐cell lung cancer: A single‐centre experience. The Clinical Respiratory Journal 14:5, pages 471-480.
Crossref
William C. Chen, Joe D. Baal, Ulysis Baal, Jonathan Pai, Alexander Gottschalk, Lauren Boreta, Steve E. Braunstein & David R. Raleigh. (2020) Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients. International Journal of Radiation Oncology*Biology*Physics 107:1, pages 48-61.
Crossref
S. Corradini, F. Alongi, N. Andratschke, C. Belka, L. Boldrini, F. Cellini, J. Debus, M. Guckenberger, J. Hörner-Rieber, F. J. Lagerwaard, R. Mazzola, M. A. Palacios, M. E. P. Philippens, C. P. J. Raaijmakers, C. H. J. Terhaard, V. Valentini & M. Niyazi. (2019) MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiation Oncology 14:1.
Crossref
Matthew N. Mills, Abhinav V. Reddy, Logan Richardson, K. Martin Richardson & Charles R. Kersh. (2019) The Prognostic Role of Pretreatment Neutrophil to Lymphocyte Ratio (NLR) in Malignant Adrenal Lesions Treated With Stereotactic Body Radiation Therapy (SBRT). American Journal of Clinical Oncology 42:12, pages 945-950.
Crossref
Elysia Donovan, Sukhbinder Dhesy‐Thind, Som Mukherjee, Michael Kucharczyk & Anand Swaminath. (2019) Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists. The Breast Journal 25:6, pages 1222-1224.
Crossref
Felipe Couñago, Javier Luna, Luis Leonardo Guerrero, Blanca Vaquero, María Cecilia Guillén-Sacoto, Teresa González-Merino, Begoña Taboada, Verónica Díaz, Belén Rubio-Viqueira, Ana Aurora Díaz-Gavela, Francisco José Marcos & Elia del Cerro. (2019) Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions. World Journal of Clinical Oncology 10:10, pages 318-339.
Crossref
Cyrielle Scouarnec, David Pasquier, Joel Luu, Florence le Tinier, Loïc Lebellec, Erwann Rault, Eric Lartigau & Xavier Mirabel. (2019) Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases. Frontiers in Oncology 9.
Crossref
Mira Mahendra Shah, Derek Isrow, Muhammad M. Fareed, Ning Wen, Samuel Ryu, Munther Ajlouni & Farzan Siddiqui. (2019) Single institution experience treating adrenal metastases with stereotactic body radiation therapy. Journal of Cancer Research and Therapeutics 15:Suppl 1, pages S27-S32.
Crossref
Xianzhi Zhao, Xiaofei Zhu, Jianfeng Fei, Haipeng Ren, Yangsen Cao, Xiaoping Ju, Zhiyong Yuan & Huojun Zhang. (2018) Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer. Radiation Oncology 13:1.
Crossref
Severin Schmid, Bernward Passlick, Martin Stuschke & Frank Griesinger. (2018) Oligometastatische Erkrankung des nichtkleinzelligen LungenkarzinomsOligometastatic disease of non-small cell lung cancer. Der Onkologe 24:12, pages 992-1002.
Crossref
Miguel A. Palacios, Omar Bohoudi, Anna M.E. Bruynzeel, John R. van Sörsen de Koste, Paul Cobussen, Ben J. Slotman, Frank J. Lagerwaard & Suresh Senan. (2018) Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases. International Journal of Radiation Oncology*Biology*Physics 102:2, pages 426-433.
Crossref
Diego A.S. Toesca, Amanda J. Koong, Rie von Eyben, Albert C. Koong & Daniel T. Chang. (2018) Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity. Advances in Radiation Oncology 3:4, pages 621-629.
Crossref
Norio Katoh, Hiroshi Onishi, Yusuke Uchinami, Tetsuya Inoue, Kengo Kuriyama, Kentaro Nishioka, Shinichi Shimizu, Takafumi Komiyama, Naoki Miyamoto & Hiroki Shirato. (2018) Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis. Technology in Cancer Research & Treatment 17, pages 153303381880998.
Crossref
Suresh Senan, Umberto Ricardi, Matthias Guckenberger, Kenneth E. Rosenzweig & Nisha Ohri. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology 342 354.e4 .
Frédéric Mercier, Liane S. Feldman & Elliot J. Mitmaker. 2018. Difficult Decisions in Endocrine Surgery. Difficult Decisions in Endocrine Surgery 395 411 .
Kristin Plichta, Nathan Camden, Muhammed Furqan, Taher Abu Hejleh, Gerald H. Clamon, Jun Zhang, Ryan T. Flynn, Sudershan K. Bhatia, Mark C. Smith, John M. Buatti & Bryan G. Allen. (2017) SBRT to adrenal metastases provides high local control with minimal toxicity. Advances in Radiation Oncology 2:4, pages 581-587.
Crossref
G. Dupic, J. Biau, A. Bellière-Calandry & M. Lapeyre. (2017) Radiothérapie stéréotaxique hypofractionnée des métastases surrénaliennes. Cancer/Radiothérapie 21:5, pages 404-410.
Crossref
K. Mohnike, K. Neumann, P. Hass, M. Seidensticker, R. Seidensticker, M. Pech, S. Klose, T. Streitparth, B. Garlipp, C. Benckert, J. J. Wendler, U. B. Liehr, M. Schostak, D. Göppner, G. Gademann & J. Ricke. (2017) Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapyRadioablation von Nebennierenmalignomen mit interstitieller High-dose-rate-Brachytherapie. Strahlentherapie und Onkologie 193:8, pages 612-619.
Crossref
William W. Chance, Quynh-Nhu Nguyen, Reza Mehran, James W. Welsh, Daniel R. Gomez, Peter Balter, Ritsuko Komaki, Zhongxing Liao & Joe Y. Chang. (2017) Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Practical Radiation Oncology 7:3, pages e195-e203.
Crossref
Julian C. Hong & Joseph K. Salama. (2017) The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?. Cancer Treatment Reviews 52, pages 22-32.
Crossref
Pranshu Bansal, Chad Rusthoven, Yanis Boumber & Gregory N Gan. (2016) The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. Future Oncology 12:23, pages 2713-2727.
Crossref
Umberto Ricardi, Serena Badellino & Andrea Riccardo Filippi. (2016) Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach. Journal of Radiation Research 57:S1, pages i58-i68.
Crossref
Nataniel H. Lester-Coll, Charles E. Rutter, Trevor J. Bledsoe, Sarah B. Goldberg, Roy H. Decker & James B. Yu. (2016) Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases. International Journal of Radiation Oncology*Biology*Physics 95:2, pages 663-672.
Crossref
Thomas Schneider, Karen Piefel & M. Heinrich Seegenschmiedt. (2016) Körperstereotaxie bei urologischen Tumoren. Uro-News 20:2, pages 37-45.
Crossref
Jennifer S. Chang, Rajni A. Sethi & Igor J. Barani. 2016. Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy. Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy 203 220 .
Thomas Schneider, Karen Piefel & M. Heinrich Seegenschmiedt. (2015) Körperstereotaxie bei urologischen Tumoren. Im Focus Onkologie 18:12, pages 54-62.
Crossref
Edy Ippolito, Rolando Maria D’Angelillo, Michele Fiore, Elisabetta Molfese, Lucio Trodella & Sara Ramella. (2015) SBRT: A viable option for treating adrenal gland metastases. Reports of Practical Oncology & Radiotherapy 20:6, pages 484-490.
Crossref
Nataniel H Lester-Coll & Roy H Decker. (2015) The role of stereotactic body radiation therapy in the management of oligometastatic lung cancer. Lung Cancer Management 4:3, pages 145-153.
Crossref
Hakan Gamsiz, Murat Beyzadeoglu, Omer Sager, Selcuk Demiral, Ferrat Dincoglan, Bora Uysal, Elif Onal & Bahar Dirican. (2015) Evaluation of Stereotactic Body Radiation Therapy in the Management of Adrenal Metastases from Non-Small Cell Lung Cancer. Tumori Journal 101:1, pages 98-103.
Crossref
Nergiz R. Dagoglu & Anand Mahadevan. 2015. Stereotactic Body Radiotherapy. Stereotactic Body Radiotherapy 233 251 .
Sridhar P. Susheela, Swaroop Revannasiddaiah & Ajaikumar Basavalingaiah. (2014) Stereotactic Hypofractionated Irradiation for Metastatic, Inoperable, and Recurrent Malignancies: A Modern Necessity, rather than a Luxury. Journal of Radiotherapy 2014, pages 1-13.
Crossref
Pierfrancesco Franco, Berardino De Bari, Patrizia Ciammella, Alba FiorentinoSilvia Chiesa, Dante Amelio, Valentina Pinzi, Pierluigi Bonomo, Stefano Vagge, Michele Fiore, Tiziana ComitoAgnese Cecconi, Gianluca Mortellaro, Alessio Bruni, Marco Trovo', Andrea Riccardo Filippi, Daniela Greto & Filippo Alongi. (2018) The Role of Stereotactic Ablative Radiotherapy in Oncological and Non-Oncological Clinical Settings: Highlights from the 7 th Meeting of AIRO – Young Members Working Group (AIRO Giovani) . Tumori Journal 100:6, pages e214-e229.
Crossref
F. Sterzing, W. Eberhardt, G. Friedel, C. Pöttgen & S. Rieken. (2014) Oligometastasiertes LungenkarzinomOligometastatic lung cancer. Der Onkologe 20:10, pages 991-997.
Crossref
Joseph K. SalamaMichael T. Milano. (2014) Radical Irradiation of Extracranial Oligometastases. Journal of Clinical Oncology 32:26, pages 2902-2912.
Crossref
Allison B. Ashworth, Suresh Senan, David A. Palma, Marc Riquet, Yong Chan Ahn, Umberto Ricardi, Maria T. Congedo, Daniel R. Gomez, Gavin M. Wright, Giulio Melloni, Michael T. Milano, Claudio V. Sole, Tommaso M. De Pas, Dennis L. Carter, Andrew J. Warner & George B. Rodrigues. (2014) An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer. Clinical Lung Cancer 15:5, pages 346-355.
Crossref
Ashray Gunjur, Cuong Duong, David Ball & Shankar Siva. (2014) Surgical and ablative therapies for the management of adrenal ‘oligometastases’ – A systematic review. Cancer Treatment Reviews 40:7, pages 838-846.
Crossref
Gregory M. M. Videtic. (2014) The Role of Stereotactic Radiotherapy in the Treatment of Oligometastases. Current Oncology Reports 16:7.
Crossref
Simon S Lo, Andrew Loblaw, Eric L Chang, Nina A Mayr, Bin S Teh, Zhibin Huang, Min Yao, Rodney J Ellis, Tithi Biswas, Jason W Sohn, Mitchell Machtay & Arjun Sahgal. (2014) Emerging applications of stereotactic body radiotherapy. Future Oncology 10:7, pages 1299-1310.
Crossref
Angelo Tozzi, Tiziana Comito, Filippo Alongi, Pierina Navarria, Cristina Iftode, Pietro Mancosu, Giacomo Reggiori, Elena Clerici, Lorenza Rimassa, Alessandro Zerbi, Antonella Fogliata, Luca Cozzi, Stefano Tomatis & Marta Scorsetti. (2013) SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. Radiation Oncology 8:1.
Crossref
Allison Ashworth, George Rodrigues, Gabriel Boldt & David Palma. (2013) Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. Lung Cancer 82:2, pages 197-203.
Crossref
Sonali Rudra, Renuka Malik, Mark C. Ranck, Karl Farrey, Daniel W. Golden, Michael D. Hasselle, Ralph R. Weichselbaum & Joseph K. Salama. (2013) Stereotactic Body Radiation Therapy for Curative Treatment of Adrenal Metastases. Technology in Cancer Research & Treatment 12:3, pages 217-224.
Crossref
Alison C Tree, Vincent S Khoo, Rosalind A Eeles, Merina Ahmed, David P Dearnaley, Maria A Hawkins, Robert A Huddart, Christopher M Nutting, Peter J Ostler & Nicholas J van As. (2013) Stereotactic body radiotherapy for oligometastases. The Lancet Oncology 14:1, pages e28-e37.
Crossref
Mohammed Yahia Almaghrabi, Stéphane Supiot, Francois Paris, Marc-André Mahé & Emmanuel Rio. (2012) Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review. Radiation Oncology 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.